Skip to main content

Research publications repository

    • čeština
    • English
  • English 
    • čeština
    • English
  • Login
View Item 
  •   CU Research Publications Repository
  • Fakulty
  • Faculty of Pharmacy in Hradec Králové
  • View Item
  • CU Research Publications Repository
  • Fakulty
  • Faculty of Pharmacy in Hradec Králové
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Novel 4-aminosalicylic acid analogues active against multidrug-resistant tuberculosis

abstract in journal
Gratis Apen Access Icon
published version
  • no other version
Thumbnail
File can be accessed.Get publication
Author
Krátký, MartinORCiD Profile - 0000-0002-4600-8409WoS Profile - T-9443-2017Scopus Profile - 6701917791
Stolaříková, Jiřina
Bősze, Szilvia
Vinšová, JarmilaORCiD Profile - 0000-0002-3272-1158WoS Profile - A-9068-2008Scopus Profile - 6701677200
,

Show other authors

Publication date
2022
Published in
Czech Chemical Society Symposium Series
Volume / Issue
20 (6)
ISBN / ISSN
ISSN: 2336-7202
Metadata
Show full item record
Collections
  • Faculty of Pharmacy in Hradec Králové
Abstract
Spread of drug-resistant Mycobacterium tuberculosis (Mtb.), together with latent tuberculosis (TB), COVID-19 co-infection and increasing prevalence of non-tuberculous mycobacteria (NTM), is a serious threat for public health justifying a strong need for new antimycobacterial agents. Modification of established drugs to obtain derivatives with improved properties represents a viable approach [1]. p-Aminosalicylic acid (PAS) is a prodrug targeting folate biosynthesis used for treatment of TB. Recently, we have published three promising PAS derivatives and their peptide conjugates as antitubercular agents [1]. Therefore, we have designed a series of novel imines and ureas based on PAS scaffold (free acid, esters, amides). Ureas were prepared from aliphatic, alicyclic, and phenylalkyl isocyanates, imines from halogenated salicylaldehydes in good yields. Some compounds were prepared to be conjugable with oligotuftsin-based peptides to improve especially their cellular uptake. Peptides were prepared by solid phase synthesis and coupled with small molecules on resin or in solution [1]. The compounds were evaluated against a panel of mycobacteria (H37Rv and drug-resistant Mtb., NTM) and other microbes, for their cytotoxic/cytostatic action, cellular uptake and intracellular antimycobacterial activity. Our PAS derivatives inhibited all mycobacterial strains with MIC ranging from 1 micromol including multidrug- and extensively resistant TB strains (MIC >= 2 micromol). In general, they showed higher potency than the parent PAS. Ureas were more active than imines, favouring n-alkyls from C8 to C13, cycloheptyl and 1-adamantyl. Most derivatives lacked cytotoxic or cytostatic effect on eukaryotic cell lines (e.g., HepG2, MonoMac6). Their coupling with oligotuftsin peptides improved physicochemical properties, cellular uptake, and intracellular activity against mycobacteria. Their mechanism of action is under investigation.
Keywords
4-aminosalicylic acid analogues, multidrug-resistant tuberculosis
Permanent link
https://hdl.handle.net/20.500.14178/1703
License

Tento výsledek je zpřístupněn v režimu gratis open access, tj. pouze pro čtení. V souladu s § 30 zákona č. 121/2000 Sb., autorského zákona, lze plný text z repozitáře také stáhnout, případně vytisknout, ale pouze pro osobní potřebu.

xmlui.dri2xhtml.METS-1.0.item-publication-version-

DSpace software copyright © 2002-2016  DuraSpace
Contact Us | Send Feedback
Theme by 
Atmire NV
 

 

About Repository

About This RepositoryResearch outputs typologyRequired metadataDisclaimerCC Linceses

Browse

All of DSpaceCommunities & CollectionsWorkplacesBy Issue DateAuthorsTitlesSubjectsThis CollectionWorkplacesBy Issue DateAuthorsTitlesSubjects

DSpace software copyright © 2002-2016  DuraSpace
Contact Us | Send Feedback
Theme by 
Atmire NV